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IMPORTANCE Myopia is a leading cause of untreatable visual impairment and is increasing in
prevalence worldwide. Interventions for slowing childhoodmyopia progression have shown
success in randomized clinical trials; hence, there is a need to identify which children would
benefit most from treatment intervention.
OBJECTIVES To examine whether genetic information alone can identify children at risk of
myopia development and whether including a child’s genetic predisposition to educational
attainment is associated with improved genetic prediction of the risk of myopia.
DESIGN, SETTING, AND PARTICIPANTSMeta-analysis of 3 genome-wide association studies
(GWAS) including a total of 711 984 individuals. These were a published GWAS for educational
attainment and 2 GWAS for refractive error in the UK Biobank, which is a multisite cohort
study that recruited participants between January 2006 and October 2010. A polygenic risk
score was applied in a population-based validation sample examined between September
1998 and September 2000 (Avon Longitudinal Study of Parents and Children [ALSPAC]
mothers). Data analysis was performed from February 2018 toMay 2019.
MAIN OUTCOMES ANDMEASURES The primary outcomewas the area under the receiver
operating characteristic curve (AUROC) in analyses for predicting myopia, using
noncycloplegic autorefractionmeasurements for myopia severity levels of less than or equal
to −0.75 diopter (D) (any), less than or equal to −3.00 D (moderate), or less than or equal to
−5.00 D (high). The predictor variable was a polygenic risk score (PRS) derived from
genome-wide association study data for refractive error (n = 95 619), age of onset of
spectacle wear (n = 287 448), and educational attainment (n = 328917).
RESULTS A total of 383067 adults aged 40 to 69 years from the UK Biobank were included
in the new GWAS analyses. The PRS was evaluated in 1516 adults aged 24 to 51 years from
the ALSPACmothers cohort. The PRS had an AUROC of 0.67 (95% CI, 0.65-0.70) for myopia,
0.75 (95% CI, 0.70-0.79) for moderate myopia, and 0.73 (95% CI, 0.66-0.80) for high
myopia. Inclusion in the PRS of information associated with genetic predisposition to
educational attainment marginally improved the AUROC for myopia (AUROC, 0.674
vs 0.668; P = .02), but not those for moderate and highmyopia. Individuals with a PRS
in the top 10%were at 6.1-fold higher risk (95% CI, 3.4–10.9) of highmyopia.
CONCLUSIONS AND RELEVANCE A personalizedmedicine approachmay be feasible for
detecting very young children at risk of myopia. However, accuracy must improve further
to merit uptake in clinical practice; currently, cycloplegic autorefraction remains a better
indicator of myopia risk (AUROC, 0.87).
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M yopia is a refractive error that typically developsduring adolescence to cause poor distance vision.It is associated with an increased risk of sight-
threatening diseases, such as glaucoma, maculopathy, and
retinal detachment.1 Successful randomized clinical trials of
interventions designed to slow childhood myopia progression
suggest it would be beneficial to identify children at high risk
of myopia development, who would benefit most from early
treatment intervention.2-5 Currently, the best predictor of
children at risk is a low hyperopic refractive error at an age
before myopia typically manifests,6 suggesting that a screen-
ing regimen of cycloplegic autorefraction would be an effec-
tive approach. However, the necessity for cycloplegia in
young children makes this strategy resource and time expen-
sive. Furthermore, as the transition from moderate to low
hyperopia may be part of the process of myopia development,
cycloplegic autorefraction screening may detect children too
late if the aim is to instigate a prophylactic intervention.
Estimating disease risk using genetic prediction, that is,
via a polygenic risk score (PRS), has the advantage of allow-
ing at-risk individuals to be identified at any age from birth
onward. No eye drops or physical assessments are required,
and the same test of a blood or saliva sample can be used to
predict a wide range of conditions.7
Currently, the best-performingPRS for refractive error ex-
plains 7.8% of the interindividual variance in the trait.8 This
PRS was derived from 7307 genetic variants identified in a
genome-wide association study (GWAS) for mean spherical
equivalent (MSE) refractive error and age of onset of spec-
tacle wear (AOSW) in 160420 participants.8 Combining par-
ticipant data for a trait of interest with participant data for
1 or more genetically correlated traits has been shown to im-
prove genetic prediction of the trait of interest.9,10Herein,we
tested thehypothesis that combiningparticipantdata fromge-
netic studies of refractive error and genetic studies of educa-
tional attainment—a trait that is genetically correlatedwith re-
fractive error—wouldbe associatedwith improvements in the
accuracy of a PRS in predicting individuals at risk of myopia.
Methods
OfthevariousapproachesforcreatingaPRS,thefollowing4-step
method has been shown to be effective7,9 andwas adopted for
the present study. In step 1, 1 or more GWAS analyses are per-
formed for the trait of interest. In step 2, which is optional, if
more than 1 GWAS has been performed, the summary results
from the separate GWAS samples are meta-analyzed to in-
crease the effective sample size. In step 3, account is taken for
thenonindependenceofgeneticmarkers inlocalregions,termed
linkage disequilibrium (LD). In step 4, the PRS for an individual
in the test population, such as a child whose risk of myopia is
unknown, is calculated by summing the LD-adjusted regres-
sion coefficient for each GWASmarker by the number of cop-
ies of the risk allele the individual carries.
The study adhered to theDeclaration of Helsinki andwas
conducted in compliance with laws in the United Kingdom.11
All participantsprovidedwrittenconsenteitherviaahardcopy
or electronic consent form. For the UK Biobank, ethical
approval was obtained from the National Health Service
National Research Ethics Service.12 For ALSPAC, written in-
formed consent for the use of data collected via question-
naires and clinics was obtained from participants following
the recommendations of the ALSPAC Ethics and Law
Committee at the time.
Multitrait analysis of GWAS (MTAG) meta-analysis9 has
been proposed as a method superior to conventional (eg, in-
verse variance weighted) meta-analysis for combining infor-
mation fromdisparate traits instep2.Herein,wesought tocap-
ture information about genetic risk from the associated traits
autorefraction-measured MSE and AOSW-inferred MSE. The
genetic correlation of a pair of related traits has been pro-
posed as a guide to their utility in an MTAG-derived PRS.9
To find the best-performing PRS generated using either a
single trait or multiple traits, we assessed PRSs generated
from the following 3 GWAS samples or traits: (1) a GWAS for
autorefraction-measured MSE, (2) a GWAS for AOSW-
inferred MSE, and (3) a GWAS for years spent in full-time
education (EduYears) (see third paragraph of Statistical
Analysis section). Additional PRSs were then calculated after
using MTAG to combine GWAS summary statistics for mul-
tiple traits. The performance of each PRS was evaluated in
an independent validation sample.
Validation Sample
The validation sample comprised mothers whose children
were enrolled in the Avon Longitudinal Study of Parents and
Children (ALSPAC).12,13 Pregnant women resident in Avon,
England, with expected dates of delivery April 1, 1991, to
December 31, 1992, were invited to take part in the study.
The initial number of pregnancies enrolled was 14 541, and
13988 children were alive at age 1 year. ALSPAC parents who
attended the research clinic with their child or children for
autorefraction at the age of 7 years were invited to undergo
noncycloplegic autorefraction themselves. There was a total
of 1516 ALSPAC mothers with autorefraction data and geno-
type data available.13 The ALSPAC study website contains
details of all of the data that are available through a fully
searchable data dictionary and variable search tool.14
Key Points
Question Can genetic information be used to predict children
at risk of myopia development?
Findings In this meta-analysis of 3 genome-wide association
studies, a polygenic risk score derived from 711 984 participants
was evaluated in an independent validation sample of 1516
participants. The area under the receiver operating characteristics
curve for predicting myopia was 0.67 and for predicting high
myopia was 0.73; individuals with polygenic risk scores in the
top 10% appeared to be at a 6.0-fold higher risk of highmyopia.
Meaning A personalizedmedicine approach appears to be
feasible for detecting very young children aged 0 to 6 years
at risk of myopia; however, beyond the age of 6 years,
cycloplegic autorefraction seems to perform better.
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Statistical Analysis
Step 1 involved GWAS analyses and meta-analysis of sum-
mary data. A GWAS for autorefraction-measured refractive
error was carried out in 95 619 UK Biobank participants of
European ancestry aged 40 to 69 years who underwent
noncycloplegic autorefraction. Details of the sample and the
GWAS parameters have been reported previously.8,15
AGWASforAOSW-inferredMSEwascarriedout in287448
UK Biobank participants of European ancestry aged 40 to 69
years who did not undergo autorefraction; that is, there was
no overlap with the autorefraction-measured MSE GWAS
sample. The GWAS parameters were the same as those used
for the GWAS for autorefraction-measured MSE. The AOSW-
inferredMSEphenotypewasderivedusing information about
the participants’ age, sex, and self-reportedAOSW (question-
naire item,What age did you first start towear glasses or con-
tact lenses?) as described in eMethods 1 in the Supplement.
In out-of-sample validation tests, the coefficient of determi-
nation between autorefraction-measured MSE and AOSW-
inferredMSEwas R2 = 0.30. All statistical tests were 2-sided.
We interpreted P values in accordancewith the 2016 Position
Statement of the American Statistical Association.16
Summarystatistics foraGWASforEduYearsbyOkbayetal17
in 328 917 participants were downloaded from the Social
Science Genetic Association Consortium website.18 In step 2,
GWAS summary statistics were combined using MTAG,9
which relies on the assumption that effects sizes for all
single-nucleotide polymorphisms share the same variance–
covariance matrix to combine GWAS summary statistics from
different traits togenerate trait-specific regressioncoefficients.9
Step 3 was designed to account for LD between GWAS
markers. LDpred19 uses a bayesian model to calculate poste-
riormean effect sizes for each GWASmarker, based on the lo-
cal LD pattern in an ancestry-matched reference sample. We
used the LDpred, version 1.0.6, infinitesimal model for ap-
proximately 1.1 million HapMap3 variants, with 2500 ran-
domly selected UK Biobank participants of European ances-
try as the LD reference panel. Constructing a PRS using a very
large number of genetic markers (eg, 1.1 million) has been re-
ported to provide better prediction performance than simply
selecting the most strongly associated GWASmarkers.7,10,19
A PRS was calculated for each of the 1516 ALSPAC moth-
ers in the validation sample, using the regression coefficients
generated by LDpred for 1.1 million HapMap3 variants. The
mother’s refractive error (noncycloplegic autorefractionmea-
sure) was regressed on the standardized PRS to calculate the
variance explained (R2) by thePRS (eMethods 2 in the Supple-
ment). Similarly, the area under the curve (AUC) of the re-
ceiver operating characteristics (ROC) curvewas calculated in
the validation sample for 3 myopia severity levels: any myo-
pia (autorefraction-measuredMSE≤−0.75 diopter [D]),mod-
erate myopia (autorefraction-measured MSE ≤ −3.00 D), and
highmyopia (autorefraction-measuredMSE≤−5.00D).To test
for an improvement in the AUC of 2 ROC curves, we used the
roc.test function from the R, version 3.5.0 package pROC
(RFoundation) (eMethods3 in theSupplement).20Wealso cal-
culated the odds ratio for myopia for participants in the top
25th, 10th, and 5th percentiles of the PRS vs the remaining
participants (eMethods 4 in the Supplement). For compari-
son with the PRS derived from 1.1 million HapMap3 variants,
we also assessed the accuracy of a PRS derived from just the
most strongly associatedGWASvariants. This assessmentwas
carried out using P value–based clumping and thresholding
(so called P+T) using the default settings of the PRSice
software21 (modified to include the X chromosome).
The genetic correlation of each trait with autorefraction-
measured MSE was determined with LDscore regression,22
using the GWAS summary statistics for each trait. Statistical
analyses were performed using R, version 3.5.0 (R Founda-
tion). All R2 values quoted are adjusted R2. Data analysis was
performed from February 2018 to May 2019.
Results
Genetic Correlations
The genetic correlation between autorefraction-measured
MSEvs theAOSW-inferredMSEphenotypewas rg = +0.92,con-
sistent with the close association between an early AOSW
and a more negative refractive error. The genetic correlation
between autorefraction-measured MSE vs EduYears was
rg = −0.26,andforAOSW-inferredMSEvsEduYears, rg = −0.35.
The negative correlation resulted from higher educational
attainment being associated with a more negative refractive
error.23 The magnitude of these genetic correlations was
deemed sufficient to warrant testing the hypothesis that
integrating GWAS summary data for refractive error and
EduYears would increase the accuracy of a PRS for refractive
error and myopia.
Accuracy of a PRS for Prediction of Refractive Error
Accuracy inpredicting refractive errorwas assessed in the all-
femalevalidation sampleusingaPRSderived fromeachGWAS
trait alone (ie, autorefraction-measuredMSE, AOSW-inferred
MSE, or EduYears) or multiple GWAS traits combined using
MTAGmeta-analysis, as shown inFigure 1A andTable 1. In all
of these analyses, the PRS for each participant was generated
using genotypes for 1.1millionvariants. ThePRSderived from
the EduYears GWAS alone provided limited predictive accu-
racy (R2 = 0.14%), while the PRS derived from either autore-
fraction-measuredMSEaloneorAOSW-inferredMSEalonehad
a similar level ofperformance (R2 = 7.1%vsR2 = 6.9%). Includ-
ing any 2 of the traits together improved performance, with
the best result obtained for autorefraction-measured MSE
combinedwithAOSW-inferredMSE(R2 = 10.8%).Forall 3 traits
combined, predictive performance improved further com-
pared with the PRS without EduYears (R2 = 11.2% vs 10.8%;
model fitP = .005). Adjustment for theparticipants’ age prior
to estimating the accuracy of the PRS did not substantially
change these R2 values.
For comparisonwith the previouslymentioned PRSs that
incorporated 1.1milliongeneticvariants,wealsoevaluated the
performance of simpler PRSs derived from just the most
strongly associated GWAS variants. The highest accuracy
(R2 = 6.3%) was obtained with a P value threshold of .01 for a
PRS derived from 7372 variants (Figure 1B).
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Performance of a PRS for the Prediction ofMyopia
The ROC curves and their corresponding AUC for the predic-
tion of low, moderate, and high myopia in the validation
sample are displayed in Figure 2 and the eFigure in the
Supplement. Consistent with the performance in predicting
refractive error, the PRS derived from theMTAG-basedmeta-
analysis of autorefraction-measured MSE, AOSW-inferred
MSE, and EduYears GWAS data demonstrated the highest
area under the receiver operating characteristic curve
(AUROC). This 3-trait PRS had AUROC values of 0.67 (95% CI,
0.65-0.70) for any myopia, 0.75 (95% CI, 0.70-0.79) for mod-
erate myopia, and 0.73 (95% CI, 0.66-0.80) for high myopia.
There was weak statistical support that the inclusion of
GWAS summary data for EduYears marginally improved the
AUROC for myopia (PRS derived with vs without information
from the GWAS: 0.674 vs 0.668; P = .02), but not the AUROC
for moderate (0.745 vs 0.742; P = .61) or high (0.730 vs
0.730; P = .98) myopia. Individuals with risk scores in the
upper percentiles of the 3-trait PRS had an increased risk of
myopia. Specifically, those with a PRS in the top 25% were at
3.0-fold to 5.0-fold higher risk of low, moderate, and high
myopia, those in the top 10% were at 3.5-fold to 6.0-fold
higher risk, while those in the top 5% were at 4.5-fold to
6.5-fold higher risk (Table 2; Figure 3). Of these results, argu-
ably the most striking was that individuals with a PRS in the
top 10% were at a 6.1-fold higher risk (95% CI, 3.4–10.9) of
high myopia compared with the remaining 90% of the
sample. Adjusting for the participants’ age did not substan-
tially change these AUC values.
Discussion
The results of this study suggest that, through advances in
genetics, it is now possible to categorize a sample of children
into 3 groups: a group at low risk of myopia and high myopia
development, making up 75% of the sample; a high-risk
group, comprising 25% of the sample who are at 3.0-fold to
5.0-fold increased risk; and a very high-risk subsample of
the latter group, compromising 10% of the sample who are at
5.0-fold to 6.0-fold increased risk. The latter 2 groups may
benefit most from an intervention to reduce the incidence of
myopia, such as time outdoors, or to reduce the rate of myo-
pia progression, such as orthokeratologic or atropine treat-
ment. Nevertheless, genetic prediction remains far from
perfect (the best AUROC was 0.75 for predicting moderate
myopia) and it was less accurate than the previously
reported approach of screening for a low level of hyperopia
by cycloplegic autorefraction.6 For instance, in the Collab-
orative Longitudinal Evaluation of Ethnicity and Refractive
Error study, the criterion of a cycloplegic autorefraction less
than or equal to +0.75 D at age 6 years had an AUROC value
of 0.87 for predicting incident myopia.6 The key advantage
of genetic prediction over cycloplegic refraction is that the
genetic approach could be used at very young ages, before
any reduction in childhood hyperopia begins. However, as
no prophylactic treatment intervention is currently available
for preventing incident myopia (other than the advice for
children to spend more time outdoors), this advantage is
currently likely to be of academic interest rather than suffi-
cient to recommend any change in clinical practice.
From the perspective of generating the best PRS for pre-
dictingrefractiveerror,our findingssupport thehypothesis that
inclusion of GWAS summary data for educational attainment
is beneficial. For example, the accuracy of a PRS was im-
proved (R2 = 10.8% vs 11.2%, model fit P = .005), as was the
AUROC for predicting myopia (AUROC = 0.674 vs 0.668,
P = .02). Nevertheless, these gains were modest considering
the large sample sizeof theEduYearsGWAS (n = 328917).Con-
sistent with earlier work,9,10,19 we found that a PRS derived
from just the topGWASvariantswas less accurate than thePRS
derived from variants distributed across the whole genome
(R2 = 6.3% for the PRS derived from 7372 top GWAS variants
vs R2 = 11.2% for the PRS derived from 1.1 million variants)
(Figure 1). In comparison with prior research to develop a
PRS for refractive error, Tedja et al8 reported the previously
Figure 1. Accuracy of Predicting Refractive Error
Using a Polygenic Risk Score (PRS)
EduYears (N = 328 917)
AOSW-inferred MSE (N = 287 448)
Autorefraction MSE (N = 95 619)
Autorefraction MSE and EduYears
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Autorefraction MSE and AOSW-inferred
MSE (N = 383 067)
Autorefraction MSE, AOSW-inferred
MSE, and EduYears (N = 711 984)
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Traits combined to create polygenic risk scoreA
Accuracy of Polygenic Risk Score (R2; %)
5 × 10–8 (N = 301)
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.1 (N = 27 949)
>.99 (N = 123 614)
P value thresholdB
Accuracy of Polygenic Risk Score (R2; %)
A, The PRSs were created using genome-wide association study (GWAS)
summary statistics for the traits, autorefraction-measuredmean spherical
equivalent (MSE), age of onset of spectacle wear (AOSW)-inferredMSE, and
years spent in full-time education (EduYears), either individually or combined
bymulti-trait analysis of GWAS (MTAG)meta-analysis. Each PRS included
information from approximately 1.1 million genetic variants. The number in
parentheses is the combined number of individuals in the GWAS analyses used
to create the PRS. B, The PRSs were derived by P value–based clumping and
thresholding (also known as P+T) using PRSice. Summary statistics from the
MTAGmeta-analysis of GWAS for autorefraction-measuredMSE,
AOSW-inferredMSE, and EduYears were used as input. The y-axis indicates the
P value threshold used for the thresholding step. The number in parentheses is
the number of genetic variants used to create the PRS. R2 values are the
adjusted R2. Error bars represent the SE.
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best-performing PRS (R2 = 7.8% in adults), which was
derived from7307genetic variants. GhorbaniMojarrad et al24
reported that a PRS derived using the top 149 GWAS variants
identifiedbyTedja et al8hadR2 valuesof 1.1%and2.6% inchil-
dren aged 7 and 15 years, respectively. By contrast, the same
149-variant PRSs had an R2 of 4.0% in the adult validation
sample that we studied herein. Thus, predicting refractive
error in childhood appears to be a more difficult task than
predicting the refractive error an individual will attain by
adulthood. However, the lack of cycloplegia in the Ghorbani
Mojarrad et al24 study sample would have contributed to the
imprecision of the PRS in children.
Table 1. Polygenic Risk Scores for Predicting Refractive Error, Derived From Each of 3 GWAS Traits Separately or in Combinationa
Trait No. of Individualsb MTAG Performed Polygenic Risk Score R2, %c
Autorefraction-measured MSE 95 619 No 7.1
AOSW-inferred MSE 287 448 No 6.9
EduYears 328 917 No 0.1
Autorefraction-measured
MSE and AOSW-inferred MSE 383 067 Yes 10.8
MSE and EduYears 424 536 Yes 7.9
MSE, AOSW-inferred MSE, and EduYears 711 984 Yes 11.2
Abbbreviations: AOSW, age of onset of spectacle wear; EduYears, years spent
in full-time education; GWAS, genome-wide association studies; MSE, mean
spherical equivalent; MTAG, multi-trait analysis of GWAS.
a Traits included autorefraction-measuredMSE, AOSW-inferredMSE, and
EduYears.
b The combined number of individuals in the GWAS analyses used to create the
polygenic risk score.
c All polygenic risk scores were created using genotype data for approximately
1.1M genetic variants. R2 values are the adjusted R2.
Figure 2. Receiver Operating Characteristic Curves for DetectingMyopia Using Polygenic Risk Scores
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Polygenic risk scores were calculated by combing information from
genome-wide association study summary data for the traits, autorefraction-
measuredmean spherical equivalent (MSE), age of onset of spectacle wear
(AOSW)-inferredMSE, and years spent in full-time education (EduYears).
AUC indicates area under the curve.
Table 2. Odds Ratios forMyopia of at Least −0.75, −3.00, and −5.00Diopters (D) for Individuals
Classified as High Risk Using a Polygenic Risk Score
Myopia Level
Group, %
Odds Ratio (95% CI) P ValueRisk Reference
≤−0.75 D Top 25 Remaining 75 3.06 (2.40-3.91) 1.75 × 10−19
Top 10 Remaining 90 3.47 (2.43-4.91) 9.70 × 10−13
Top 5 Remaining 95 4.57 (2.84-7.51) 7.11 × 10−10
≤−3.00 D Top 25 Remaining 75 4.66 (3.06-7.03) 3.93 × 10−13
Top 10 Remaining 90 4.89 (3.41-7.06) 8.14 × 10−18
Top 5 Remaining 95 5.42 (3.17-9.03) 1.95 × 10−10
≤−5.00 D Top 25 Remaining 75 4.90 (2.81-8.72) 3.22 × 10−8
Top 10 Remaining 90 6.11 (3.36-10.87) 1.20 × 10−9
Top 5 Remaining 95 6.50 (3.14-12.48) 1.37 × 10−7
Odds ratios were calculated by
comparing those in the high-risk
group with the remainder of
the population.
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Limitations and Strengths
Our study has several limitations. First, it illustrates that, as
expected from quantitative genetics theory, there are dimin-
ishing returns in the predictive accuracy of a PRS as the effec-
tiveGWASsample size increases. Asmentioned in thepreced-
ing paragraph, at the GWAS sample sizes currently available,
genetic prediction is unable to match the performance of
cycloplegic autorefraction in predicting children at risk of
myopia (AUROC = 0.67 vs0.87).6 Another limitationwas that
we only studied participants of European ancestry. A PRS
derived for use in one ancestry group is expected to perform
poorly in a separate ancestry group.25 GWAS studies that re-
cruit more participants of non-European ancestry will be
beneficial to investigate prediction of refractive error and
myopia in non-European ancestry populations. Strengths of
the study were the use of very large GWAS samples for deriv-
ing the PRS, evaluation of the PRS in a completely indepen-
dent validation sample, andmeasurement of refractive error
usingnoncycloplegicautorefraction,which is thecriterionstan-
dard approach for this age range (24-69 years).26
Conclusions
Prediction of children at high (3.0-fold to 5.0-fold) and very
high (4.5-fold to 6.5-fold) risk ofmyopia andhighmyopiawas
estimated using genetic information alone. Sensitivity and
specificity did not reach the levels obtainable using cyclople-
gic autorefraction (AUC = 0.67vs0.87); however, genetic pre-
diction offers the advantages of not requiring the use of eye
drops and specialist clinical assessment and could be used to
detect children who would benefit from interventions to
prevent incident myopia (eg, more time outdoors) as well as
to slow myopia progression. Incorporating genetic informa-
tion capturing aspects of future educational attainment was
found to be associated with improved accuracy of the PRS in
predictingmyopia, although the gain wasmodest. This work
suggests that a personalized medicine approach to detecting
children at risk of myopia is now feasible, although currently
the accuracy of PRSs is not yet good enough to warrant their
use in clinical practice.
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The values of the PRS have been standardized to aid interpretation. The PRS
was derived from the combined summary statistics of autorefraction-measured
mean spherical equivalent, age of onset of spectacle wear–inferredmean
spherical equivalent, and years spent in full-time education. The odds ratio for
highmyopia was more than 4 times for individuals in the top 25th percentile
of the PRS (yellow and orange shaded regions combined) vs the remainder
of the population. The odds ratio for highmyopia was more than 6 times for
individuals in the top 10th percentile of the PRS (orange shaded region)
vs the remainder of the population. The dotted blue line indicates a
standardized polygenic risk score of 0.
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